BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12750297)

  • 1. 3'-[18F]fluoro-3'-deoxythymidine ([18F]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human disease.
    Wagner M; Seitz U; Buck A; Neumaier B; Schultheiss S; Bangerter M; Bommer M; Leithäuser F; Wawra E; Munzert G; Reske SN
    Cancer Res; 2003 May; 63(10):2681-7. PubMed ID: 12750297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorine-18-Labeled Thymidine Positron Emission Tomography (FLT-PET) as an Index of Cell Proliferation after Pharmacological Ascorbate-Based Therapy.
    Cieslak JA; Sibenaller ZA; Walsh SA; Ponto LL; Du J; Sunderland JJ; Cullen JJ
    Radiat Res; 2016 Jan; 185(1):31-8. PubMed ID: 26720803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [18F]FLT-PET in oncology: current status and opportunities.
    Been LB; Suurmeijer AJ; Cobben DC; Jager PL; Hoekstra HJ; Elsinga PH
    Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1659-72. PubMed ID: 15565331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo imaging of cell proliferation in meningioma using 3'-deoxy-3'-[
    Bashir A; Binderup T; Vestergaard MB; Broholm H; Marner L; Ziebell M; Fugleholm K; Kjær A; Law I
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1496-1509. PubMed ID: 32047966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual time point [
    Lovinfosse P; Rousseau C; Pierga JY; Bouchet F; Cochet A; Alberini JL; Girault S; Vera P; Olivier P; Uwer L; Cachin F; Scarwell B; Lemonnier J; Fourme E; Mesleard C; Martin AL; Lacœuille F; Couturier OF
    EJNMMI Res; 2019 Dec; 9(1):109. PubMed ID: 31832803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vertebral 3'-deoxy-3'-
    Umeda Y; Tsujikawa T; Anzai M; Morikawa M; Waseda Y; Kadowaki M; Shigemi H; Ameshima S; Mori T; Kiyono Y; Okazawa H; Ishizuka T
    Eur Radiol; 2019 Jul; 29(7):3908-3917. PubMed ID: 30972546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative skeletal distribution of proliferating marrow in the adult dog determined using 3'-deoxy-3'-[
    Rowe JA; Morandi F; Osborne DR; Wall JS; Kennel SJ; Reed RB; LeBlanc AK
    Anat Histol Embryol; 2019 Jan; 48(1):46-52. PubMed ID: 30353574
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Wieder H; Beer AJ; Siveke J; Schuster T; Buck AK; Herrmann K; Stollfuss JC
    Oncotarget; 2018 Feb; 9(11):10128-10134. PubMed ID: 29515797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Positron Emission Tomography Tracer 3'-Deoxy-3'-[18F]Fluorothymidine ([18F]FLT) Is Not Suitable to Detect Tissue Proliferation Induced by Systemic Yersinia enterocolitica Infection in Mice.
    Wiehr S; Rolle AM; Warnke P; Kohlhofer U; Quintanilla-Martinez L; Reischl G; Autenrieth IB; Pichler BJ; Autenrieth SE
    PLoS One; 2016; 11(10):e0164163. PubMed ID: 27701464
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Osgood CL; Tantawy MN; Maloney N; Madaj ZB; Peck A; Boguslawski E; Jess J; Buck J; Winn ME; Manning HC; Grohar PJ
    Sci Rep; 2016 Sep; 6():33926. PubMed ID: 27671553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET.
    Wong PK; Lee ST; Murone C; Eng J; Lawrentschuk N; Berlangieri SU; Pathmaraj K; O'Keefe GJ; Sachinidis J; Byrne AJ; Bolton DM; Davis ID; Scott AM
    Asia Ocean J Nucl Med Biol; 2014; 2(1):3-11. PubMed ID: 27408853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in PET Detection of the Antitumor T Cell Response.
    McCracken MN; Tavaré R; Witte ON; Wu AM
    Adv Immunol; 2016; 131():187-231. PubMed ID: 27235684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors.
    Seiler SM; Baumgartner C; Hirschberger J; Beer AJ; Brühschwein A; Kreutzmann N; Laberke S; Wergin MC; Meyer-Lindenberg A; Brandl J; von Thaden AK; Farrell E; Schwaiger M
    PLoS One; 2015; 10(6):e0127800. PubMed ID: 26068641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the specificity of [(18)F]fludarabine PET/CT in a xenograft model of follicular lymphoma: comparison with [(18)F]FDG and impact of rituximab therapy.
    Hovhannisyan N; Guillouet S; Fillesoye F; Dhilly M; Patin D; Galateau F; Leporrier M; Barré L
    EJNMMI Res; 2015; 5():23. PubMed ID: 25977881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy.
    Mena E; Lindenberg ML; Turkbey BI; Shih J; Logan J; Adler S; Wong K; Wilson W; Choyke PL; Kurdziel KA
    Clin Nucl Med; 2014 Oct; 39(10):874-81. PubMed ID: 25144214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations of (18)F-fluorothymidine uptake with pathological tumour size, Ki-67 and thymidine kinase 1 expressions in primary and metastatic lymph node colorectal cancer foci.
    Nakajo M; Nakajo M; Kajiya Y; Goto Y; Jinguji M; Tanaka S; Fukukura Y; Tani A; Higashi M
    Eur Radiol; 2014 Dec; 24(12):3199-209. PubMed ID: 25120206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCL.
    Herrmann K; Buck AK; Schuster T; Abbrederis K; Blümel C; Santi I; Rudelius M; Wester HJ; Peschel C; Schwaiger M; Dechow T; Keller U
    Oncotarget; 2014 Jun; 5(12):4050-9. PubMed ID: 24979177
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Tan Y; Liang J; Liu D; Zhu F; Wang G; Ding X; Han C
    Exp Ther Med; 2014 Jul; 8(1):69-72. PubMed ID: 24944599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomographic monitoring of dual phosphatidylinositol-3-kinase and mTOR inhibition in anaplastic large cell lymphoma.
    Graf N; Li Z; Herrmann K; Weh D; Aichler M; Slawska J; Walch A; Peschel C; Schwaiger M; Buck AK; Dechow T; Keller U
    Onco Targets Ther; 2014; 7():789-98. PubMed ID: 24920919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of early changes in 3H-fluorothymidine uptake after treatment with gefitinib in human tumor xenograft in comparison with Ki-67 and phospho-EGFR expression.
    Zhao S; Kuge Y; Zhao Y; Takeuchi S; Hirata K; Takei T; Shiga T; Dosaka-Akita H; Tamaki N
    BMC Cancer; 2013 Nov; 13():525. PubMed ID: 24191959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.